Quantum BioPharma Provides Corporate Update
Stocks in this Quantisnow insightHealth Care
Historical context for QNTM
Across the 19 sessions after earlier QNTM headlines, the stock closed higher 8 times and lower 11 times, with a median move of 11.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | QNTM | SPY |
|---|---|---|---|
| May 18, 2026 | Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital | -7.9% | -0.1% |
| May 7, 2026 | Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026 | -5.1% | -0.3% |
| Apr 28, 2026 | Quantum BioPharma Provides Corporate Update | +20.7% | -0.5% |
| Apr 22, 2026 | Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant | -2.6% | +1.0% |
| Apr 2, 2026 | Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied | -9.8% | +0.1% |
| Mar 30, 2026 | Quantum Biopharma Provides Corporate Update | -10.3% | -0.3% |
Quantisnow market dataNASDAQ
QNTM
Quantum Biopharma Ltd.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for QNTM
Full QNTM profile on Quantisnow Follow QNTM and get a push notification the moment its next story breaks.